Refine by
Drug Therapy Articles & Analysis
82 articles found
Applications of Transcriptome Analysis The wide application of transcriptomics in biomedical research is of great significance in understanding the basic mechanisms of life, revealing the molecular mechanisms of disease development, and discovering new therapeutic targets and drugs, including the following directions: Analysis of Gene Expression Regulation l Study the ...
Precise and safe delivery of drugs to target sites has always been an important task for researchers in modern medicine. ...
As fibrosis develops, patients experience worsening shortness of breath, reduced lung capacity and ultimately respiratory failure. Current therapies for IPF rely on oral administration of pirfenidone and nintedanib, two FDA-approved drugs that slow disease progression. ...
Conversely, low metabolic stability can lead to rapid clearance from the system, necessitating modifications in the chemical structure to enhance the drug’s longevity. Moreover, S9 assays help in predicting drug-drug interactions. ...
In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. Among the most promising strategies in this domain is the development of radioactive drug conjugates(RDCs). ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
Watertown, MA – March 24, 2025 – Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion.Structural Advantages of DSPE-PEG-MannoseDSPE-PEG-Mannose ...
In the realm of drug discovery, the search for innovative therapies often leads to new paradigms. ...
The classification of anti-tumor APIs often falls into four main types: chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormone therapy drugs. ...
By creating cell lines with specific genes “knocked out,” scientists can investigate disease mechanisms, screen drug candidates, and develop gene therapies more effectively. This article explores the significance, methodologies, applications, and future prospects of custom knockout cell lines. ...
Understanding and analyzing these biomolecules has become increasingly important in areas such as disease research, biomarker discovery, and drug development. NAD and NADH are not merely passive participants in metabolism—they are regulatory molecules that influence key metabolic pathways, including glycolysis, oxidative phosphorylation, and biosynthetic reactions. ...
As the landscape of cancer treatment continues to evolve, there is a growing need for innovative and personalized therapeutic approaches. Conventional therapies often fall short in their ability to selectively target cancer cells without impacting healthy tissues. ...
This initiative represents a critical advancement in pursuing effective bladder cancer therapies and underscores the company’s commitment to providing diverse high-quality services for various fields of cancer research. ...
Prolonging Drug Half-Life The process of PEGylation, which involves attaching PEG chains to therapeutic molecules, has been a game-changer in prolonging the half-life of drugs. ...
Through peptide sequencing, we can discover new peptide drugs with specific bioactivity, such as peptide hormones and peptide antibodies, providing powerful tools for targeted therapy. ...
These antibodies may reduce the effectiveness of the drug and even cause adverse reactions.Applications1. BiologicsFor biologic drugs (such as monoclonal antibodies or protein-based therapies), patients may develop anti-drug antibodies (ADA), which can neutralize the potency of the drug or accelerate its ...
Active pharmaceutical ingredients (APIs) are biologically active components in pharmaceutical drugs, responsible for the intended therapeutic effects. APIs are prepared through chemical synthesis or biotechnology, meeting stringent quality standards and regulatory requirements. ...
By leveraging deep insights into molecular structures, scientists can sculpt innovative drug candidates with unprecedented precision and finesse, ushering in a new era of personalized and targeted therapies. ...
Ongoing research and inventions in the field of oncology focus on the development of small molecule drug therapies for use in brain tumor resection. Small molecule drugs are being developed to target and effectively treat brain tumors to improve therapeutic outcomes. ...
They can usually be used to treat rheumatoid arthritis. These drugs are used to treat rheumatoid arthritis. Currently, researches on monoclonal antibody drugs development expand the range to immuno-oncology, targeted therapy, and immunotherapy. Researchers have proposed more prospects for monoclonal antibody therapy ...